[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial

Emmett, Louise, Subramaniam, Shalini, Crumbaker, Megan · The Lancet Oncology · 2024